AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 109 filers reported holding AXSOME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $527 | -48.8% | 7,546 | -47.4% | 0.00% | -100.0% |
| Q2 2023 | $1,030 | +2929.4% | 14,341 | +2460.9% | 0.00% | – |
| Q1 2023 | $34 | -97.3% | 560 | -96.6% | 0.00% | -100.0% |
| Q4 2022 | $1,262 | -99.9% | 16,362 | -57.0% | 0.00% | -50.0% |
| Q3 2022 | $1,697,000 | +68.4% | 38,051 | +44.5% | 0.00% | +100.0% |
| Q2 2022 | $1,008,000 | +2358.5% | 26,340 | +2534.0% | 0.00% | – |
| Q1 2022 | $41,000 | -94.8% | 1,000 | -95.2% | 0.00% | -100.0% |
| Q4 2021 | $790,000 | +12.1% | 20,927 | +102.5% | 0.00% | 0.0% |
| Q3 2021 | $705,000 | -0.7% | 10,335 | -1.9% | 0.00% | 0.0% |
| Q2 2021 | $710,000 | +3636.8% | 10,535 | +3026.1% | 0.00% | – |
| Q1 2021 | $19,000 | – | 337 | -94.9% | 0.00% | – |
| Q4 2020 | $0 | – | 6,622 | -39.1% | 0.00% | – |
| Q3 2020 | $0 | – | 10,867 | -15.6% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 12,879 | -45.9% | 0.00% | -100.0% |
| Q1 2020 | $1,401,000 | +400.4% | 23,822 | +778.1% | 0.00% | +100.0% |
| Q4 2019 | $280,000 | -48.9% | 2,713 | -90.0% | 0.00% | -50.0% |
| Q3 2019 | $548,000 | +194.6% | 27,084 | +106.8% | 0.00% | +100.0% |
| Q1 2019 | $186,000 | +18500.0% | 13,097 | +3174.2% | 0.00% | – |
| Q4 2018 | $1,000 | – | 400 | +300.0% | 0.00% | – |
| Q3 2018 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |